Drugging the Next Undruggable KRAS Allele-Gly12Asp

被引：24
|
作者：
Zheng, Qinheng [1 ]
Peacock, D. Matthew [1 ]
Shokat, Kevan M. [1 ]
机构：
[1] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2022年 / 65卷 / 04期
关键词：
K-RAS; BIND;
D O I：
10.1021/acs.jmedchem.2c00099
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Since its discovery as the first human oncogene in 1983, the small GTPase KRAS has been a major target of cancer drug discovery. The paper reported in this issue describes a long-awaited small molecule drug candidate of the oncogenic KRAS (G12D) mutant for the treatment of currently incurable pancreatic cancer.
引用
收藏
页码：3119 / 3122
页数：4
相关论文
共 50 条
  • [41] Discovery of novel potent allele-selective KRAS-G12C covalent inhibitors stemming from DNA-encoded library
    McCort, Gary
    Arrebola, Rosalia
    Calvet, Loreley
    Ronan, Baptiste
    Vergne, Fabrice
    Duffieux, Francis
    Rak, Alexey
    Meaux, Isabelle
    Papin, David
    Fassy, Florence
    Delorme, Cecile
    Matthieu, Magali
    Nicolas, Jean-Paul
    Marcireau, Christophe
    Steier, Valerie
    Abecassis, Pierre-Yves
    Czepczor, Valerie
    Thomson, Heather A.
    Hupp, Christopher D.
    Guilinger, J. P.
    Zhang, Ying
    Keefe, Anthony D.
    Cuozzo, John W.
    Liu, Julie
    Debussche, Laurent
    CANCER RESEARCH, 2019, 79 (13)
  • [42] DIFFERENTIAL INTERACTIONS OF RABBIT PLATELET GPIIB-IIIA WITH THE FIBRINOGEN GAMMA-CHAIN DODECAPEPTIDE (H12) AND ARG-GLY-ASP (RGD) PEPTIDES
    RAND, ML
    YEO, EL
    GEMMELL, CH
    PACKHAM, MA
    LAM, SCT
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1196 - 1196
  • [43] 2-DIMENSIONAL H-1-NMR STUDY OF A TETRADECAPEPTIDE WITH THE CONSENSUS SEQUENCE ARG(5)-ASP-VAL-ARG-GLY - STRUCTURAL EFFECTS OF THE OUTSIDE SUBSTITUTION SER(12) BY ALA(12)
    RIAND, J
    CHALAOUX, FR
    LESENEY, AM
    BARON, D
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 1995, 12 (05): : 993 - 1008
  • [44] Full-length sequence of the novel HLA-C*12:02:36 allele by next generation sequencing in a Chinese individual
    Wu, Fan
    Li, Zhen
    Shao, Chao-Peng
    HLA, 2020, 96 (05) : 650 - 651
  • [45] The novel HLA-DQB1*03:01:01:12 allele, identified by next-generation sequencing in a Chinese family
    Wu, R.
    Li, R.
    Zhang, Y.
    Li, H.
    Sun, H.
    HLA, 2018, 91 (03) : 221 - 222
  • [46] A Novel HLA-C Allele, HLA-C*12:419, Was Identified by Next-Generation Sequencing in a Chinese Individual
    Huang, Ti-Long
    Zhang, Tian-Yao
    Xiang, Lin
    Jiang, Hong-Chao
    Zhang, Xian-Wen
    HLA, 2024, 104 (06)
  • [47] Developing KRAS G12C inhibitor-resistant tumor models for efficacy evaluation of next-generation anticancer therapies
    Zhou, Jun
    Ye, Zi
    Bo, Ning
    Zhang, Dan
    Hua, Li
    Nie, Chenpan
    Wang, Jingjing
    Kumari, Rajendra
    Price, Leo
    Xu, Xiaoxi
    CANCER RESEARCH, 2023, 83 (07)
  • [48] DECLINED PRESENTATION KRASG12D INITIATES ACUTE T-CELL LYMPHOBLASTIC LEUKEMIA IN COOPERATION WITH LOSS OF THE WILD-TYPE KRAS ALLELE
    Staffas, Anna
    Karlsson, Christin
    Palmqvist, Lars
    Bergo, Martin
    EXPERIMENTAL HEMATOLOGY, 2013, 41 (08) : S49 - S49
  • [49] Dynamics of KRAS G12/13 allele burden in circulating tumor DNA predicts survival in patients with unresectable pancreatic cancer undergoing palliative chemotherapy
    Johansen, J. S.
    Vibat, C. R. T.
    Hancock, S.
    Chen, I.
    Samuelsz, E.
    Collisson, E. A.
    Jensen, B. V.
    Melnikova, V.
    Erlander, M. G.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S470 - S471
  • [50] KO-2806, a next-generation farnesyl transferase inhibitor, re-sensitizes KRAS G12C NSCLC tumors to KRAS G12C mutant-specific inhibitors through mTOR signaling inhibition
    Patel, H.
    Chan, S.
    Smith, A.
    Burrows, F.
    Malik, S.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S146 - S146
12345